MEMPHIS, Tenn. - Tennsun -- BIOTRONIK, a global leader in cardiac monitoring technology, is proud to announce a new partnership with MiCare Path, a pioneer in digital health solutions, to deliver a comprehensive Remote Physiologic Monitoring (RPM) program for cardiology practices. This collaboration is designed to empower clinics to seamlessly extend care beyond the office visit, driving improved patient outcomes.

BIOTRONIK's BIOMONITOR IV insertable cardiac monitor (ICM) devices can now be combined with a MiCare Path RPM device. The package features either a cellular-enabled blood pressure monitor or weight scale, and a patient mobile app that provides clinics with a turnkey solution to launch or expand their cardiac RPM programs. This integration supports both patients with BIOMONITOR IV devices and the broader clinical cardiology network.

More on tennsun.com

• iVAM2-ST2110 to Simplify IP Transitions and Reduce Monitoring Complexity
• Americans Leave Behind or Discard 42% of Their Belongings When Moving Out for the First Time, Talker Research Finds
• Central Florida Luxury Real Estate Firm DANHOLM COLLECTION Partners with Luxury Presence to Expand Global Buyer Reach
• Advantage Marketing Launches 3-Minute Assessment to Help SMBs Diagnose and Fix Marketing Gaps
• InterMountain Management Announces the Re-opening of Holiday Inn Express & Suites Alexandria

This collaboration underscores the dedication of both organizations to deliver best-in-class solutions that simplify clinical workflows while enhancing patient engagement and satisfaction. By combining BIOTRONIK's proven cardiac monitoring technology with MiCare Path's scalable RPM platform, clinics are equipped to deliver comprehensive, data-driven care for today's cardiac patients.

"This partnership represents the next evolution in personalized cardiac care," said Ryan Walters, President of BIOTRONIK, Inc. "MiCare Path's innovative approach to virtual care complements our mission of delivering excellence for life. Together, we are giving providers new tools to see the whole picture so they can act faster with greater confidence, helping patients live healthier, longer lives."

"Our customers have been asking for deeper insight, broader coverage, and smarter care – this cooperation comes as a direct response to these," said Scott Laster, CEO of MiCare Path. "We're proud to work alongside the team at BIOTRONIK, whose reputation for precision and clinical commitment is unmatched in the industry."

More on tennsun.com

• CB Stuffer Expands New England Footprint with Launch at Common Man Roadside in Hooksett, NH
• Contracting Resources Group Named to the 2026 Inc. Regionals: Mid-Atlantic List
• Dividend Stock Guru Unveils High Yield Dividend Stock Research Reports
• Charging Into the $30 Billion Heart Failure Market with Late-Stage Momentum, Breakthrough Data, & Strong Financial Backing: Cardiol Therapeutics $CRDL
• Owner to Dueño Revolutionizes Homeownership in Memphis with Accessible Owner-to-Owner Financig

BIOTRONIK has built a reputation for engineering excellence, reliability, and a relentless dedication to patient outcomes. With presence in more than 100 countries and over 60 years of medical innovation with an outstanding quality record, BIOTRONIK empowers physicians with technologies that support timely decision-making, patient safety, and long-term clinical success. This partnership further extends BIOTRONIK's vision for a connected and patient-centered future.

Over the past six years, MiCare Path has deployed its virtual care platform to tens of thousands of patients nationwide, enabling providers to extend care beyond the office visit through remote monitoring, chronic and principal care management, and intelligent real-time alerts. The integration with BIOMONITOR IV allows care teams to track arrhythmias and cardiac events more comprehensively, delivering peace of mind to both clinicians and patients.

For more information, visit http://www.biotronik.com or http://www.micarepath.com.